SCHEMBL16207488

SCHEMBL16207488

COC(=O)C(C)c1c(F)cc(Br)cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 2/20 0.38
ALDH1A1 P00352 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
NOTUM Q6P988 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
NFKB1 P19838 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
APLNR P35414 2/20 0.34
MT-CO2 P00403 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.33
DGAT1 O75907 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16207383 0.84 TAS1R3 (0.40) PTGS1PTGS2MEN1KMT2ASMN1; SMN2
SCHEMBL16207444 0.82 PTGS1 (0.36) PTGS1PTGS2MEN1KMT2ASMN1; SMN2
SCHEMBL16207458 0.81 TSHR (0.35) PTGS1PTGS2MEN1KMT2A
SCHEMBL16207545 0.80 SMN1; SMN2 (0.40) ALDH1A1PTGS1PTGS2NOTUMMEN1
SCHEMBL28915928 0.79 AKR1C3 (0.40) PTGS1PTGS2MEN1KMT2ALMNA
SCHEMBL20681094 0.79 SLC6A3 (0.37) ALDH1A1PTGS1PTGS2MEN1KMT2A
SCHEMBL16207392 0.78 GAA (0.40) ALDH1A1L3MBTL1MEN1KMT2ALMNA
SCHEMBL2130305 0.78 APLNR (0.50) AAK1ALDH1A1L3MBTL1PTGS1PTGS2
SCHEMBL16585353 0.78 KMT2A (0.47) ALDH1A1PTGS1PTGS2MEN1KMT2A
SCHEMBL16554601 0.77 ERN1 (0.37) ALDH1A1L3MBTL1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2799424-B1 2-FLUOROPHENYLPROPIONIC ACID DERIVATIVE LTT BIO PHARMA CO LTD (JP) 2016-08-17 EP disclosed
US-9221786-B2 2-fluorophenyl propionic acid derivatives LTT BIO-PHARMA CO., LTD. (JP) 2015-12-29 US disclosed
US-9221786-B2 2-fluorophenyl propionic acid derivatives LTT BIO-PHARMA CO., LTD. (JP) 2015-12-29 US disclosed
US-9221786-B2 2-fluorophenyl propionic acid derivatives LTT BIO-PHARMA CO., LTD. (JP) 2015-12-29 US disclosed
US-20140330026-A1 2-FLUOROPHENYL PROPIONIC ACID DERIVATIVES LTT BIO-PHARMA CO., LTD. (JP) 2014-11-06 US disclosed
US-20140330026-A1 2-FLUOROPHENYL PROPIONIC ACID DERIVATIVES LTT BIO-PHARMA CO., LTD. (JP) 2014-11-06 US disclosed
US-20140330026-A1 2-FLUOROPHENYL PROPIONIC ACID DERIVATIVES LTT BIO-PHARMA CO., LTD. (JP) 2014-11-06 US disclosed
EP-2799424-A1 2-FLUOROPHENYLPROPIONIC ACID DERIVATIVE LTT Bio-Pharma Co., Ltd. (JP) 2014-11-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140330026-A1 2-FLUOROPHENYL PROPIONIC ACID DERIVATIVES FPR1, OPRK1, FPR2 AAK1 2197/4885ALDH1A1 57/4885L3MBTL1 3173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.